Validation of a prioritization tool

  • Validation of a prioritization tool

    Posted by Eric on February 10, 2026 at 10:17 pm

    Hi,

    I am an EM pharmacist in Montreal, Canada and we have developed a prioritization tool to identify patients that would most likely need pharmacist involvement during their stay. We have studied it at our sites and are we now at the validation step.

    After evaluating it in close to 400 patients and adjusting the variables, we have a sensitivity of 0.74 and specificity of 0.9 within our two hospitals (one is a Level 1 Trauma center and the other is a transplant/onco/ECMO center) when comparing the tool to manual pharmacists’ prioritization.

    Once we have identified participating sites in the US, I will provide you with a REB approved protocol from our hospital that will need to be approved at your site. Our research legal department will also be in contact with yours to organize data transfer contracts.

    Potential benefits of the tool:

    In EDs that do not have a pharmacist coverage 24/7, when you arrive in the morning with 60-100 patients, it is faster to prioritize your patients with the tool rather than looking manually at the list of patients. If you have 24/7 pharmacist coverage, the advantage may come from being able to prioritize new patients that arrived while you were in Resus (let’s say for the last 2-3 hours), you would then be able to run the tool and you will see if some of the new ones are coming up as top priority. It also helps with harmonizing patient identification.

    What will be expected from the participating centers:

    <ul type=”disc”>

  • One person who will
    be in charge of submitting for ethics, organizing the data
    collection, gathering the reports, and sending them our way.
    This person will be offered authorship for the publication of the
    results.
  • Each
    site will have to arrange a report with EPIC that includes all the
    variables we had at the beginning of our project, so you remain
    blinded to the one we kept, and the cutoffs chosen. The more than 60
    variables used are a mix of vital signs, labs, PMHx and a few medications.
    (We can discuss if you are not using EPIC and believe that you can
    generate the necessary report)
  • Duration
    of data collection will vary on the size of your site, but our
    statistician calculated that 638 patients per center will need to be
    prioritized (e.g. if you have 60 patients on stretchers that would be
    10 days of data collection, not consecutive to avoid looking at the same
    patient twice in a same visit)
  • Technically
    it is a 3-person job, always the same 2 pharmacists prioritize the
    patients independently in 3 groups (urgent (within the next 2 hours), to
    be seen (at some point today), not prioritized) and a 3rd pharmacist
    resolves the discrepancies without knowing the prioritization of the
    2 other pharmacists. We do not have EPIC but it took us about 1-1.5 min
    per patient.
  • The goal is to validate in at least 3 American centers with various profiles (Teaching vs community hospitals, 24/7 vs 8 hrs per day)

    The targeted timeline for data collection is during the summer/fall 2026 or earlier if ready (hopefully).

    If you have questions or are interested


    Eric Villeneuve BPharm, MSc, PharmD, ASHP accredited PGY2 (CC/EM)

    Pharmacist – Clinical leader, Adult Emergency medicine
    Pharmacy department

    Centre universitaire de santé McGill
    McGill University Health Centre

    Site Glen
    1001 boul. Décarie, bureau CRC.6004
    Montréal QC Canada H4A 3J1
    Tél. 514-934-1934 ext. 66566 ou/or 23844
    eric.villeneuve@muhc.mcgill.ca

Eric replied 7 months, 1 week ago 1 Member · 0 Replies
  • 0 Replies

    Sorry, there were no replies found.

    Log in to reply.